Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of ARS 256.33 trillion. The enterprise value is 321.47 trillion.

Market Cap	256.33T
Enterprise Value	321.47T

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Nov 21, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.28%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	80.83%
Float	537.12M

Valuation Ratios

The trailing PE ratio is 26.70 and the forward PE ratio is 15.92.

PE Ratio	26.70
Forward PE	15.92
PS Ratio	5.20
PB Ratio	19.44
P/TBV Ratio	n/a
P/FCF Ratio	16.21
P/OCF Ratio	14.25
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.35, with an EV/FCF ratio of 20.33.

EV / Earnings	33.49
EV / Sales	6.19
EV / EBITDA	13.35
EV / EBIT	19.96
EV / FCF	20.33

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 5.67.

Current Ratio	1.28
Quick Ratio	0.82
Debt / Equity	5.67
Debt / EBITDA	3.27
Debt / FCF	4.73
Interest Coverage	3.32

Financial Efficiency

Return on equity (ROE) is 81.71% and return on invested capital (ROIC) is 10.56%.

Return on Equity (ROE)	81.71%
Return on Assets (ROA)	7.71%
Return on Invested Capital (ROIC)	10.56%
Return on Capital Employed (ROCE)	16.33%
Revenue Per Employee	1.76B
Profits Per Employee	342.87M
Employee Count	28,000
Asset Turnover	0.40
Inventory Turnover	1.57

Taxes

In the past 12 months, Amgen has paid 1.70 trillion in taxes.

Income Tax	1.70T
Effective Tax Rate	15.03%

Stock Price Statistics

The stock price has increased by +66.72% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+66.72%
50-Day Moving Average	15,643.00
200-Day Moving Average	13,147.30
Relative Strength Index (RSI)	53.42
Average Volume (20 Days)	2,743

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.07

Income Statement

In the last 12 months, Amgen had revenue of ARS 49.30 trillion and earned 9.60 trillion in profits. Earnings per share was 17,725.81.

Revenue	49.30T
Gross Profit	34.53T
Operating Income	15.29T
Pretax Income	11.30T
Net Income	9.60T
EBITDA	22.59T
EBIT	15.29T
Earnings Per Share (EPS)	17,725.81

Full Income Statement

Balance Sheet

The company has 12.94 trillion in cash and 74.81 trillion in debt, giving a net cash position of -61,867.11 billion.

Cash & Cash Equivalents	12.94T
Total Debt	74.81T
Net Cash	-61,867.11B
Net Cash Per Share	n/a
Equity (Book Value)	13.18T
Book Value Per Share	24,480.67
Working Capital	8.35T

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 17.99 trillion and capital expenditures -2,174.98 billion, giving a free cash flow of 15.81 trillion.

Operating Cash Flow	17.99T
Capital Expenditures	-2,174.98B
Free Cash Flow	15.81T
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.05%, with operating and profit margins of 31.02% and 19.47%.

Gross Margin	70.05%
Operating Margin	31.02%
Pretax Margin	22.92%
Profit Margin	19.47%
EBITDA Margin	45.82%
EBIT Margin	31.02%
FCF Margin	32.08%

Dividends & Yields

This stock pays an annual dividend of 292.66, which amounts to a dividend yield of 1.71%.

Dividend Per Share	292.66
Dividend Yield	1.71%
Dividend Growth (YoY)	64.28%
Years of Dividend Growth	14
Payout Ratio	72.03%
Buyback Yield	-0.28%
Shareholder Yield	1.43%
Earnings Yield	3.75%
FCF Yield	6.17%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on January 24, 2024. It was a forward split with a ratio of 3.

Last Split Date	Jan 24, 2024
Split Type	Forward
Split Ratio	3

Scores

Amgen has an Altman Z-Score of 1.69 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.69
Piotroski F-Score	7